Akoustis Technologies Inc expected to post a loss of 20 cents a share - Earnings Preview

Aktis Oncology

29/10/2021 13:52

* Akoustis Technologies Inc  AKTS.OQ   AKTS.O  is expected
to show a rise in quarterly revenue when it reports results on
November 1. 
* The Huntersville, North Carolina-based company is expected to
report  a 216.7% increase in revenue to $2.014 million from $636
thousand a year ago, according to the mean estimate from 4
analysts, based on Refinitiv data. 
​* Refinitiv's mean analyst estimate for Akoustis Technologies
Inc is for a loss of 20 cents per share. For the same quarter
last year, the company reported a loss of 31 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for Akoustis
Technologies Inc is $17​, about 55.9% above​ its last closing
price of $7.50. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Jun. 30 2021  -0.21       -0.19      -0.23     Missed  -23.2
 Mar. 31 2021  -0.27       -0.28      -0.22     Beat    20.5
 Dec. 31 2020  -0.25       -0.23      -0.22     Beat    6.4​
 Sep. 30 2020  -0.23       -0.23      -0.31     Missed  -37.2
 Jun.          -0.22​      -0.22      -0.27     Missed  -20.9​
 30​ 2020​                                              
 Mar. 31 2020  -0.24       -0.25      -0.21     Beat    15.2​
 Dec. 31 2019  -0.26       -0.26      -0.30     Missed  -15.4
 Sep. 30 2019  -0.22       -0.23      -0.30     Missed  -28.3
 This summary was machine generated October 29 at 12:52 GMT.  All
figures in US dollars unless otherwise stated